SODIUM CHLORIDE 0.45 % WV AND GLUCOSE 5 % WV B.BRAUN Israël - Engels - Ministry of Health

sodium chloride 0.45 % wv and glucose 5 % wv b.braun

lapidot medical import and marketing ltd - glucose monohydrate; sodium chloride - solution for infusion - glucose monohydrate 55 mg / 1 ml; sodium chloride 4.5 mg / 1 ml - electrolytes with carbohydrates - sodium chloride 0.45 % w/v and glucose 5 % w/v b. braun is indicated to provide electrolytes and calories and is a source of water for hydration. sodium chloride 0.45 % w/v and glucose 5 % b.braun is a vehicle solution for compatible medicinal products.

Sodium Chloride Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

sodium chloride

baxter healthcare ltd - sodium chloride 0.45% - solution for infusion - 0.45 % - active: sodium chloride 0.45% - hypotonic sodium chloride (0.45%) intravenous infusion is mainly used as a hydrating agent solution.

Sodium Chloride Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

sodium chloride

baxter healthcare ltd - sodium chloride 3% - solution for infusion - 3 % - active: sodium chloride 3% - hypertonic sodium chloride (3%) intravenous infusion is used in the management of severe sodium chloride depletion when electrolyte restoration is required.

Sodium Chloride 0.9% Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

sodium chloride 0.9%

multichem nz limited - sodium chloride 9 mg/ml - solution for injection - 0.9% w/v - active: sodium chloride 9 mg/ml excipient: water for injection

Sodium Chloride 0.3 % w/v and Glucose 3.3% w/v Solution for Infusion BP Ierland - Engels - HPRA (Health Products Regulatory Authority)

sodium chloride 0.3 % w/v and glucose 3.3% w/v solution for infusion bp

baxter healthcare limited - sodium chloride; glucose monohydrate - solution for infusion - 0.3 3.3 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.45 % w/v and Glucose 2.5% w/v Solution for Infusion BP Ierland - Engels - HPRA (Health Products Regulatory Authority)

sodium chloride 0.45 % w/v and glucose 2.5% w/v solution for infusion bp

baxter healthcare limited - sodium chloride; sodium chloride; glucose monohydrate; glucose monohydrate - solution for infusion - 0.45 2.5 percent weight/volume - salt solutions; sodium chloride

Sodium Chloride 0.9 % w/v and Glucose 5% w/v Solution for Infusion BP (Viaflo container) Ierland - Engels - HPRA (Health Products Regulatory Authority)

sodium chloride 0.9 % w/v and glucose 5% w/v solution for infusion bp (viaflo container)

baxter healthcare limited - sodium chloride; sodium chloride; glucose monohydrate; glucose monohydrate - solution for infusion - 0.9/5 %w/v percent weight/volume - salt solutions; sodium chloride

HYDROXYETHYL STARCH IN SODIUM CHLORIDE injection, solution Verenigde Staten - Engels - NLM (National Library of Medicine)

hydroxyethyl starch in sodium chloride injection, solution

b. braun medical inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - hydroxyethyl starch 130/0.4 6 g in 100 ml - 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection is indicated for the treatment and prophylaxis of hypovolemia in adults and children. it is not a substitute for red blood cells or coagulation factors in plasma. - do not use hydroxyethyl starch (hes) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy (rrt).  - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with severe liver disease. - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with known hypersensitivity to hydroxyethyl starch [see general warnings and precautions (5.1) ] - do not use hes products in clinical conditions with volume overload.  - do not use hes products in patients with pre-existing coagulation or bleeding disorders.  - do not use h